Skip to main content

Blue Cross and Blue Shield of North Carolina expands Specialty Pharmacy precertification list (Healthy Blue + Medicare (HMO D-SNP))

Please note, this communication applies to Healthy Blue + Medicare (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective for dates of service on and after October 1, 2023, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

HCPCS or CPT® CodesMedicare Part B Drugs
J9999Adstiladrin (nadofaragene firadenovec-vncg)
J3490, J3590Altuviiio (antihemophilic factor (recombinant)
J3490, J3590Idacio (adalimumab-aacf)
C9399, J3490Lamzede (velmanase alfa-tycv)
C9399, J3490, J3590, J9999Lunsumio (mosunetuzumab-axgb)
C9399, J3490, J3590Rebyota (fecal microbiota, live – jslm)
J2502Signifor LAR (pasireotide)
C9399, J3490Syfovre (pegcetacoplan) 
J9999Vivimusta (bendamustine)

For more information, please visit Healthy Blue + Medicare.